BERWYN, PA and WATFORD, UK — AscellaHealth has announced its acquisition of CHAPPER healthcare, a renowned global specialty pharmaceutical wholesaler and distributor. This strategic move enhances AscellaHealth’s ability to serve international markets, expanding its reach to over 70 countries across Europe, Asia, Africa, Australia, and the Americas.
The integration of CHAPPER healthcare is set to bolster AscellaHealth’s global market leadership. “The integration of CHAPPER healthcare into the AscellaHealth organization consolidates overall global market leadership, unlocking new opportunities for market access and product commercialization throughout the global life sciences industry,” stated Bill Oldham, chairman and president of AscellaHealth. This acquisition is expected to strengthen their customer value proposition by delivering innovative solutions and expanding patient support programs worldwide.
CHAPPER healthcare is recognized for its expertise in the import and export of specialty pharmaceuticals, offering logistical solutions and ensuring access to critical medications. Their role as a founding member of EUROPACCESS highlights their commitment to providing streamlined access to European healthcare systems.
Mario Patone, CFO of AscellaHealth, emphasized the strategic importance of this acquisition, noting, “A strategic transaction in the U.K. with access to global markets underscores our shared commitment to shaping the future of healthcare, driving business growth and expanding our international presence.”
The partnership with CHAPPER healthcare will enhance AscellaHealth’s capabilities in managing the supply of named patient medicines, including those for rare diseases. This acquisition aligns with AscellaHealth’s mission to break down barriers to care and drive advancements in the specialty pharmaceutical landscape.
Jonathan Chapper, CEO of CHAPPER healthcare, expressed enthusiasm about joining AscellaHealth, saying, “We are excited about the opportunity to join forces with the impressive AscellaHealth team and advance global access to vital medicines, particularly in times of urgent need.”
With this acquisition, AscellaHealth is poised to significantly accelerate its global market presence and operational scale, further solidifying its position as a trusted partner in the pharmaceutical industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.